Today: 20 March 2026
Subscribe
Browse Category

SWX:CS 10 November 2025 - 30 December 2025

XRP price today: Ripple token slides below $2 as Fed minutes loom, ETF inflows hold up

XRP price today: Ripple token slides below $2 as Fed minutes loom, ETF inflows hold up

XRP fell 2.1% to $1.86 in early New York trading Tuesday, slipping below $2 as cryptocurrencies weakened into year-end. CoinShares reported $70.2 million in inflows to XRP-linked funds last week, despite $446 million in total crypto outflows. Traders are watching Fed minutes due later Tuesday and key levels near $2. Bitcoin traded around $87,600, ether near $2,970.
30 December 2025
····
XRP treads water near $1.85 as crypto fund outflows persist ahead of Fed minutes

XRP treads water near $1.85 as crypto fund outflows persist ahead of Fed minutes

XRP traded near $1.85 Monday, down 0.01% over 24 hours as crypto markets stayed quiet ahead of year-end. Digital-asset investment products saw $446 million in outflows last week, with total withdrawals since October reaching $3.2 billion, according to CoinShares. Bitcoin slipped 0.14% to $89,551 and ether fell 0.12% to $2,967. Traders await Federal Reserve minutes due Tuesday for policy signals.
29 December 2025
···
Crypto This Week & Week Ahead (Dec. 13, 2025): Bitcoin Near $90K as U.S. Bank Charters, a Staked Ethereum ETF Filing, and Tokenization Headlines Reshape the Market

Crypto This Week & Week Ahead (Dec. 13, 2025): Bitcoin Near $90K as U.S. Bank Charters, a Staked Ethereum ETF Filing, and Tokenization Headlines Reshape the Market

Bitcoin held near $90,000 Saturday, steady after a volatile year marked by rallies and risk shocks. The Federal Reserve cut rates by 25 basis points this week, but internal divisions signaled a slower easing path. U.S. regulators advanced new crypto banking charters and ETF filings tied to Ethereum staking. Bitcoin remains closely linked to broader market sentiment, after peaking above $126,000 in October.
13 December 2025
···
Bitcoin Reclaims $92K as Fed Rate-Cut Hopes Lift Crypto – But Is the Return of Confidence Enough?

Bitcoin Reclaims $92K as Fed Rate-Cut Hopes Lift Crypto – But Is the Return of Confidence Enough?

Bitcoin climbed above $92,000 during Monday’s Asia session as traders anticipated a Federal Reserve rate cut. The total crypto market cap rose 2.2% to about $3.2 trillion, with 90 of the top 100 coins in the green. Bitcoin ETFs saw $352 million in inflows last week, while short-Bitcoin funds posted their largest outflows since March. Despite the rebound, Bitcoin remains down over 10% for the month.
8 December 2025
···
XRP Today (Nov. 10, 2025): DTCC Lists Spot XRP ETFs, Profit‑Taking Jumps to $220M, and a Solana Dev’s ‘Scam’ Remark Sparks Debate

XRP Today (Nov. 10, 2025): DTCC Lists Spot XRP ETFs, Profit‑Taking Jumps to $220M, and a Solana Dev’s ‘Scam’ Remark Sparks Debate

Five spot XRP ETFs from issuers including Bitwise and Franklin Templeton appeared on the DTCC’s “active/pre-launch” list, signaling progress but not SEC approval. On-chain data shows long-term XRP holders realizing about $220 million in daily profits as prices cool. A Solana developer publicly called XRP a “scam,” fueling debate. XRP’s market value stands near $135 billion.
10 November 2025
···

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop